Skip to main content

View full-text article in PMC

. 2006 Oct 9;2006(5):30490. doi: 10.1155/MI/2006/30490

Table 2.

ICAM-1, iNOS, and COX-2 protein production in vehicle and theaflavin-treated groups ( $\bar{x}$ ± s n = 10).

Parameters	Dose	ICAM-1	iNOS	COX-2
Parameters	(mg · kg⁻¹)	(number of immunopositive/mm²)	(number of immunopositive/mm²)	(number of immunopositive/mm²)

Vehicle	—	166.21 ± 34.26	61.21 ± 20.34	67.41 ± 22.29
Sham	—	12.36 ± 7.09	13.24 ± 6.98	10.36 ± 7.06
TF1	5	97.28 ± 24.67^**	42.11 ± 21.06^**	39.14 ± 21.74^**
TF1	10	63.12 ± 22.30^**	31.21 ± 16.57^**	28.57 ± 12.39^**
TF1	20	32.17 ± 16.55^**	24.88 ± 14.89^**	21.36 ± 14.21^**
Nimodipine	1	38.66 ± 19.87^**	24.31 ± 15.33^**	23.61 ± 12.58^**

**denotes that P < .01 versus the vehicle-treated group.